{
    "clinical_study": {
        "@rank": "95700", 
        "arm_group": [
            {
                "arm_group_label": "In-Center Use of Mifepristone", 
                "arm_group_type": "No Intervention", 
                "description": "Participants who choose to take mifepristone in the center"
            }, 
            {
                "arm_group_label": "Out-of-Center Use of Mifepristone", 
                "arm_group_type": "Experimental", 
                "description": "Participants who choose to take the mifepristone outside of the center"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will test ways to give women more options and flexibility when they are ending\n      their unwanted pregnancies.  The investigators will look at uptake and acceptability of\n      using mifepristone outside of the clinic for pregnancy termination."
        }, 
        "brief_title": "Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion", 
        "condition": "Termination of Pregnancy", 
        "detailed_description": {
            "textblock": "This study will investigate the uptake of mifepristone administration outside of the health\n      center for pregnancy termination and its acceptability to women and to their providers.  In\n      addition, we plan to evaluate rates of follow-up, adherence, efficacy, complications, days\n      of missed work and/or school, and lost income. This will be a prospective, comparative,\n      non-randomized, open-label study. All women who are seeking medical abortion will be offered\n      participation in the study.  Women who enroll in the study will be given a choice between\n      taking the mifepristone outside the center or in the center setting."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women 18 years and older\n\n          -  seeking medical abortion services\n\n          -  in general good health\n\n          -  assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on\n             the day mifepristone will be taken\n\n          -  eligible for medical abortion according to clinician and center standards.\n\n        Exclusion Criteria:\n\n          -  will be followed up by beta HCG and not ultrasound"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01811056", 
            "org_study_id": "1006"
        }, 
        "intervention": {
            "arm_group_label": "Out-of-Center Use of Mifepristone", 
            "intervention_name": "Mifepristone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Mifepristone"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "medical abortion", 
            "mifepristone"
        ], 
        "lastchanged_date": "June 26, 2013", 
        "link": {
            "url": "http://www.gynuity.org"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Lauren Porsch", 
                    "phone": "212-274-7255"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Planned Parenthood of New York City"
                }, 
                "investigator": {
                    "last_name": "Gillian Dean, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jen Castle", 
                    "phone": "802-448-9743"
                }, 
                "facility": {
                    "address": {
                        "city": "Barre, Burlington, Rutland", 
                        "country": "United States", 
                        "state": "Vermont"
                    }, 
                    "name": "Planned Parenthood of Northern New England"
                }, 
                "investigator": {
                    "last_name": "Regan Theiler, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Tara Earley", 
                    "phone": "206-861-7518"
                }, 
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "Planned Parenthood of the Great Northwest"
                }, 
                "investigator": {
                    "last_name": "Lauren Kuehl, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion", 
        "other_outcome": [
            {
                "description": "Missed days of school and/or work Additional costs for childcare or eldercare", 
                "measure": "Productivity", 
                "safety_issue": "No", 
                "time_frame": "1-2 weeks"
            }, 
            {
                "description": "Reasons for selection of mifepristone administration site and experiences with home administration", 
                "measure": "Reasons for selection of mifepristone administration site and experiences with home administration Reason", 
                "safety_issue": "No", 
                "time_frame": "1-2 weeks"
            }
        ], 
        "overall_official": {
            "affiliation": "Gynuity Health Projects", 
            "last_name": "Beverly Winikoff, MD, MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Proportion of participants who would choose outside of center administration of mifepristone again", 
                "safety_issue": "No", 
                "time_frame": "1-2 weeks"
            }, 
            {
                "measure": "Proportion of participants who would recommend outside-of-center administration to a friend", 
                "safety_issue": "No", 
                "time_frame": "1-2 weeks"
            }
        ], 
        "reference": {
            "PMID": "23177917", 
            "citation": "Swica Y, Chong E, Middleton T, Prine L, Gold M, Schreiber CA, Winikoff B. Acceptability of home use of mifepristone for medical abortion. Contraception. 2012 Nov 21. doi:pii: S0010-7824(12)00951-1. 10.1016/j.contraception.2012.10.021. [Epub ahead of print]"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01811056"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Proportion of women who select outside-of-clinic use of mifepristone", 
                "safety_issue": "No", 
                "time_frame": "1-2 weeks"
            }, 
            {
                "description": "Ongoing pregnancy at study end Incomplete abortion at study end Medically indicated surgical intervention during study", 
                "measure": "Success Rates/Method Failure", 
                "safety_issue": "No", 
                "time_frame": "1-2 weeks"
            }, 
            {
                "description": "Did not take complete therapy Mifepristone not taken at scheduled time Mifepristone not taken within 63 days L.M.P. Misoprostol not taken within 48 hours of mifepristone administration Did not return for confirmation of outcome", 
                "measure": "Adherence", 
                "safety_issue": "No", 
                "time_frame": "1-2 weeks"
            }, 
            {
                "description": "Unscheduled visits to center Unscheduled calls to center/clinician on-call Provider satisfaction- better than center mifepristone, equivalent, or worse; impact on workload; impact on quality of care", 
                "measure": "Provider-related outcomes", 
                "safety_issue": "No", 
                "time_frame": "1-2 weeks"
            }
        ], 
        "source": "Gynuity Health Projects", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gynuity Health Projects", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}